| MFP | monofluorophosphate; myofascial pain |
|---|---|
| MPD | main pancreatic duct; maximum permissible dose; mean population doubling; membrane potential differe... |
| MPDS | mandibular pain dysfunction syndrome; myofascial pain dysfunction syndrome |
| MPS | meconium plug syndrome; medial premotor system; Member of the Pharmaceutical Society; microbial prof... |
| MPS | Myofascial Pain Syndrome |
|---|
| myofascial | Of or relating to the fascia surrounding and separating muscle tissue. (05 Mar 2000) |
|---|---|
| myofascial pain | <symptom> A large group of muscle disorders characterised by the presence of hypersensitive points, called trigger points, within one or more muscles and/or the investing connective tissue together with a syndrome of pain, muscle spasm, tenderness, stiffness, limitation of motion, weakness and occasionally autonomic dysfunction. (16 Dec 1997) |
| myofascial pain syndromes | Muscular pain in numerous body regions that can be reproduced by pressure on trigger points, localised hardenings in skeletal muscle tissue. Pain is referred to a location distant from the trigger points. A prime example is the temporomandibular joint dysfunction syndrome. (12 Dec 1998) |
| myofascial syndrome | <syndrome> Irritation of the muscles and fascia of the back and neck causing acute and chronic pain not associated with any neurological or bony evidence of disease; presumed to arise primarily from poorly understood changes in the muscle and fascia themselves. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|